Decheng Capital China Life Sciences Usd Fund Iii, L.P. is of Cue Health Inc.. Currently has a direct ownership of 8.19 Million shares of HLTH, which is worth approximately $0. The most recent transaction as insider was on Sep 28, 2021, when has been sold 8,192,468 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.19M
0% 3M change
0% 12M change
Total Value Held $0

Decheng Capital China Life Sciences USD Fund III, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 28 2021
BUY
Conversion of derivative security
-
8,192,468 Added 50.0%
8,192,468 Common Stock

Also insider at

ALPN
ALPINE IMMUNE SCIENCES, INC. Healthcare
DCC

Decheng Capital China Life Sciences Usd Fund Iii, L.P.

Grand Cayman, E9

Track Institutional and Insider Activities on HLTH

Follow Cue Health Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HLTH shares.

Notify only if

Insider Trading

Get notified when an Cue Health Inc. insider buys or sells HLTH shares.

Notify only if

News

Receive news related to Cue Health Inc.

Track Activities on HLTH